Osteoclast Signal Transduction During Bone Metastasis Formation.
bone metastases (BM)
osteoclast (OC)
osteolysis
signaling/signaling pathways
tumor
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
11
2019
accepted:
27
05
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
9
7
2020
Statut:
epublish
Résumé
Osteoclasts are myeloid lineage-derived bone-resorbing cells of hematopoietic origin. They differentiate from myeloid precursors through a complex regulation process where the differentiation of preosteoclasts is followed by intercellular fusion to generate large multinucleated cells. Under physiological conditions, osteoclastogenesis is primarily directed by interactions between CSF-1R and macrophage colony-stimulating factor (M-CSF, CSF-1), receptor activator of nuclear factor NF-κB (RANK) and RANK ligand (RANKL), as well as adhesion receptors (e.g., integrins) and their ligands. Osteoclasts play a central role in physiological and pathological bone resorption and are also required for excessive bone loss during osteoporosis, inflammatory bone and joint diseases (such as rheumatoid arthritis) and cancer cell-induced osteolysis. Due to the major role of osteoclasts in these diseases the better understanding of their intracellular signaling pathways can lead to the identification of potential novel therapeutic targets. Non-receptor tyrosine kinases and lipid kinases play major roles in osteoclasts and small-molecule kinase inhibitors are emerging new therapeutics in diseases with pathological bone loss. During the last few years, we and others have shown that certain lipid (such as phosphoinositide 3-kinases PI3Kβ and PI3Kδ) and tyrosine (Src-family and Syk) kinases play a critical role in osteoclast differentiation and function in humans and mice. Some of these signaling pathways shows similarity to immunoreceptor-like receptor signaling and involves important other enzymes (e.g., PLCγ2) and adapter proteins (such as the ITAM-bearing adapters DAP12 and the Fc-receptor γ-chain). Here, we review recently identified osteoclast signaling pathways and their role in osteoclast differentiation and function as well as pathological bone loss associated with osteolytic tumors of the bone. A better understanding of osteoclast signaling may facilitate the design of novel and more efficient therapies for pathological bone resorption and osteolytic skeletal metastasis formation.
Identifiants
pubmed: 32637413
doi: 10.3389/fcell.2020.00507
pmc: PMC7317091
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
507Informations de copyright
Copyright © 2020 Győri and Mócsai.
Références
Nat Rev Rheumatol. 2009 Oct;5(10):543-8
pubmed: 19798028
J Bone Miner Res. 2009 Jul;24(7):1142-1146
pubmed: 19558316
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6158-63
pubmed: 15073337
J Clin Invest. 2006 Nov;116(11):2869-79
pubmed: 17053833
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
J Biol Chem. 1999 Apr 16;274(16):10963-8
pubmed: 10196176
Nature. 2003 May 15;423(6937):337-42
pubmed: 12748652
PLoS Biol. 2004 Jun;2(6):e169
pubmed: 15208721
Nature. 2006 Mar 30;440(7084):692-6
pubmed: 16572175
Science. 1987 Aug 21;237(4817):893-6
pubmed: 3616618
J Clin Oncol. 2012 Aug 10;30(23):2919-28
pubmed: 22778315
J Cell Biochem. 2007 Jul 1;101(4):996-9
pubmed: 17471500
Nat Rev Cancer. 2015 Jan;15(1):7-24
pubmed: 25533673
Calcif Tissue Int. 1995 Apr;56(4):336-8
pubmed: 7767847
Cell. 1997 Apr 18;89(2):309-19
pubmed: 9108485
Arthritis Res Ther. 2009;11(1):210
pubmed: 19232069
J Bone Miner Res. 2004 Feb;19(2):224-34
pubmed: 14969392
J Cell Biochem. 1990 Nov;44(3):189-98
pubmed: 1980125
Annu Rev Cell Dev Biol. 1995;11:549-99
pubmed: 8689569
Arthritis Res Ther. 2011 May 27;13(3):219
pubmed: 21635718
Cancer Res. 2011 Jul 15;71(14):4799-808
pubmed: 21602433
J Bone Miner Res. 2017 Mar;32(3):431-433
pubmed: 28177151
J Exp Med. 2006 Nov 27;203(12):2673-82
pubmed: 17088434
Clin Exp Metastasis. 1992 Nov;10(6):403-10
pubmed: 1451350
Cancer Res. 2012 Jun 15;72(12):3000-9
pubmed: 22659453
Biochem Soc Trans. 2006 Nov;34(Pt 5):647-62
pubmed: 17052169
Cancer Res. 2003 Sep 1;63(17):5438-45
pubmed: 14500379
Nat Rev Immunol. 2007 Apr;7(4):292-304
pubmed: 17380158
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14205-10
pubmed: 14612570
Annu Rev Cell Dev Biol. 1997;13:513-609
pubmed: 9442882
Nat Rev Immunol. 2007 Jun;7(6):429-42
pubmed: 17525752
J Bone Miner Res. 2017 Mar;32(3):434-439
pubmed: 27606829
Eur J Clin Invest. 2012 Jan;42(1):49-60
pubmed: 21749368
Cell Mol Life Sci. 2017 Oct;74(19):3599-3611
pubmed: 28493076
J Biol Chem. 2004 Apr 23;279(17):17660-6
pubmed: 14739300
Ann N Y Acad Sci. 2011 Nov;1237:71-8
pubmed: 22082368
Nat Med. 2015 Mar;21(3):281-7
pubmed: 25706873
Mol Cancer Res. 2009 Apr;7(4):476-88
pubmed: 19372577
Cancer Res. 2013 Jan 15;73(2):672-82
pubmed: 23243021
Nature. 2003 May 15;423(6937):356-61
pubmed: 12748655
Cancer Res. 2003 Aug 15;63(16):5028-33
pubmed: 12941830
Curr Opin Pharmacol. 2008 Aug;8(4):427-32
pubmed: 18625340
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8
pubmed: 21383194
Nat Rev Cancer. 2002 Jul;2(7):489-501
pubmed: 12094235
Am J Pathol. 2003 Nov;163(5):2021-31
pubmed: 14578201
Ann Rheum Dis. 2009 May;68(5):744-50
pubmed: 18480308
J Exp Med. 2003 Aug 18;198(4):669-75
pubmed: 12925681
Cancer Res. 2003 Apr 1;63(7):1667-75
pubmed: 12670921
Nature. 2011 Feb 24;470(7335):548-53
pubmed: 21326202
J Clin Invest. 1997 Nov 15;100(10):2476-85
pubmed: 9366562
J Bone Miner Res. 2014 Feb;29(2):338-47
pubmed: 23821519
J Pharmacol Exp Ther. 1996 Apr;277(1):543-50
pubmed: 8613966
Nat Rev Cancer. 2016 May 25;16(6):373-86
pubmed: 27220481
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5
pubmed: 10200246
J Natl Cancer Inst. 1994 Jan 19;86(2):120-6
pubmed: 8271294
J Cell Biochem. 2009 Jul 1;107(4):639-54
pubmed: 19479902
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Endocr Rev. 2008 Apr;29(2):155-92
pubmed: 18057140
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2561-6
pubmed: 22308398
Ann N Y Acad Sci. 2010 Mar;1192:117-23
pubmed: 20392226
Int J Med Sci. 2008 Sep 03;5(5):263-72
pubmed: 18797510
Nat Rev Mol Cell Biol. 2010 Apr;11(4):288-300
pubmed: 20308986
J Biol Chem. 2008 Apr 11;283(15):9917-24
pubmed: 18250170
J Cell Biol. 2012 May 14;197(4):553-68
pubmed: 22584907
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15804-9
pubmed: 20720163
Nat Med. 2007 Jul;13(7):791-801
pubmed: 17618270
Annu Rev Pathol. 2008;3:457-84
pubmed: 18039135
Nat Med. 2009 Sep;15(9):1066-71
pubmed: 19718038
Cancer Sci. 2008 Aug;99(8):1595-602
pubmed: 18754872
Nat Rev Mol Cell Biol. 2001 Oct;2(10):760-8
pubmed: 11584303
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
J Biol Chem. 2013 Dec 6;288(49):35346-57
pubmed: 24133210
Nat Rev Mol Cell Biol. 2010 May;11(5):329-41
pubmed: 20379207
Blood. 2001 Dec 15;98(13):3527-33
pubmed: 11739153
J Bone Miner Res. 1998 Apr;13(4):688-94
pubmed: 9556069
Cancer Res. 2007 Jun 15;67(12):5821-30
pubmed: 17575150
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4485-9
pubmed: 7685105
Autoimmun Rev. 2009 Jan;8(3):250-5
pubmed: 18722561
J Bone Miner Res. 2009 Oct;24(10):1763-9
pubmed: 19419309
Annu Rev Immunol. 2013;31:675-704
pubmed: 23330955
J Immunol. 2002 Mar 1;168(5):2544-53
pubmed: 11859150
Arthritis Rheum. 2007 Dec;56(12):4104-12
pubmed: 18050211
Immunol Lett. 2006 Apr 15;104(1-2):29-37
pubmed: 16332394
Breast Cancer Res. 2006;8(2):R20
pubmed: 16608535
Nature. 2012 May 3;485(7396):69-74
pubmed: 22522930
Mol Cell Biol. 2008 Dec;28(23):7182-98
pubmed: 18809581
J Clin Invest. 2000 Feb;105(4):433-40
pubmed: 10683372
J Bone Miner Res. 2011 Nov;26(11):2665-71
pubmed: 21735477
J Bone Miner Res. 2012 Dec;27(12):2464-75
pubmed: 22806988
PLoS One. 2013 Jul 18;8(7):e68171
pubmed: 23935856
J Pathol. 2002 Oct;198(2):228-36
pubmed: 12237883
J Biol Chem. 2013 Nov 15;288(46):33347-60
pubmed: 24085298
Front Immunol. 2019 Apr 30;10:937
pubmed: 31134061
Mol Cell Biol. 2008 Jun;28(11):3610-22
pubmed: 18378693
Nat Rev Genet. 2003 Aug;4(8):638-49
pubmed: 12897775
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3117-22
pubmed: 20133620
Curr Opin Pharmacol. 2015 Aug;23:45-51
pubmed: 26051995
PLoS One. 2013 May 29;8(5):e63833
pubmed: 23734178
FEBS Lett. 1995 Mar 13;361(1):79-84
pubmed: 7890044
Front Endocrinol (Lausanne). 2018 Jun 19;9:322
pubmed: 29971044
Clin Breast Cancer. 2013 Oct;13(5):371-7
pubmed: 23810293
Oncotarget. 2016 May 17;7(20):29620-34
pubmed: 27102437
J Cell Physiol. 2015 Jan;230(1):210-25
pubmed: 24962140
Nature. 2004 Apr 15;428(6984):758-63
pubmed: 15085135
Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):15654-9
pubmed: 26644563
J Biol Chem. 1997 Oct 3;272(40):25190-4
pubmed: 9312132
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
J Bone Miner Res. 2011 Feb;26(2):229-38
pubmed: 21254230
Science. 2000 Sep 1;289(5484):1504-8
pubmed: 10968780
Nat Cell Biol. 2006 Jun;8(6):615-22
pubmed: 16715077
Nat Rev Mol Cell Biol. 2012 Feb 23;13(3):195-203
pubmed: 22358332
J Clin Immunol. 2009 Sep;29(5):555-67
pubmed: 19585227
Nature. 2015 Jun 4;522(7554):106-110
pubmed: 26017313
J Exp Med. 2010 Mar 15;207(3):579-89
pubmed: 20212065
Blood. 2003 Mar 15;101(6):2094-8
pubmed: 12424190
Cell. 1991 Feb 22;64(4):693-702
pubmed: 1997203
Cell. 2002 Sep 20;110(6):673-87
pubmed: 12297042
Biochim Biophys Acta. 2013 Jun;1830(6):3756-66
pubmed: 23458685
Science. 1979 Jan 12;203(4376):176-9
pubmed: 569363
Urology. 2001 Apr;57(4):611-6
pubmed: 11306358
Nat Med. 2006 Dec;12(12):1410-6
pubmed: 17128269
Bone. 2013 Oct;56(2):383-9
pubmed: 23867221
Cancer Cell. 2013 Oct 14;24(4):542-56
pubmed: 24135284
J Clin Med. 2015 Aug 28;4(9):1741-52
pubmed: 26343739
Endocrinology. 1999 Oct;140(10):4451-8
pubmed: 10499498
Ann Med. 1995 Feb;27(1):79-85
pubmed: 7742005
Prostate. 2010 May 15;70(7):755-64
pubmed: 20058239
J Exp Med. 2012 Feb 13;209(2):319-34
pubmed: 22249448
Science. 2000 Feb 11;287(5455):1040-6
pubmed: 10669416
J Biol Chem. 2008 Oct 24;283(43):29593-601
pubmed: 18728019
Nat Rev Immunol. 2010 Jun;10(6):387-402
pubmed: 20467426
Cell Metab. 2013 Feb 5;17(2):249-60
pubmed: 23395171
Biochem Biophys Res Commun. 2000 May 27;272(1):116-24
pubmed: 10872813
PLoS One. 2012;7(12):e50946
pubmed: 23284651
Cell. 2000 Feb 18;100(4):387-90
pubmed: 10693755
J Cell Biol. 1992 Nov;119(4):1003-13
pubmed: 1385441
Nat Commun. 2015 Mar 31;6:6637
pubmed: 25824719
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4828-32
pubmed: 2191302
J Exp Med. 2005 Sep 5;202(5):589-95
pubmed: 16147974
J Biol Chem. 2002 Jul 5;277(27):24571-8
pubmed: 11964407
J Surg Res. 2001 Sep;100(1):18-24
pubmed: 11516200
J Biol Chem. 2006 Sep 22;281(38):28011-22
pubmed: 16831863
Nat Cell Biol. 2008 Sep;10(9):1027-38
pubmed: 19160483
J Cell Biol. 1996 Aug;134(3):793-9
pubmed: 8707856
Immunol Rev. 2005 Dec;208:88-105
pubmed: 16313343
Trends Cell Biol. 2004 Nov;14(11):628-38
pubmed: 15519852
JCI Insight. 2018 Jun 7;3(11):
pubmed: 29875321
Biochim Biophys Acta. 2015 Jun;1851(6):882-97
pubmed: 25514767
Eur J Med Chem. 2012 Aug;54:463-9
pubmed: 22698703
Cancer Cell. 2005 Jun;7(6):561-73
pubmed: 15950905
Biochem Biophys Res Commun. 2007 Jun 15;357(4):1046-52
pubmed: 17462597
Cell. 1992 Apr 3;69(1):11-25
pubmed: 1555235
Clin Investig (Lond). 2011 Dec 1;1(12):1695-1706
pubmed: 22384312
Clin Cancer Res. 1995 Mar;1(3):313-25
pubmed: 9815987
Nat Rev Cancer. 2002 Aug;2(8):584-93
pubmed: 12154351
J Exp Med. 2010 Apr 12;207(4):751-62
pubmed: 20368579
Nat Med. 2005 Mar;11(3):284-90
pubmed: 15711558
Nat Rev Cancer. 2011 Jun;11(6):411-25
pubmed: 21593787
J Biol Chem. 1991 Oct 25;266(30):20369-74
pubmed: 1939092
Nat Rev Cancer. 2001 Oct;1(1):46-54
pubmed: 11900251
Cancer Treat Rev. 2008 Feb;34(1):92-101
pubmed: 17964729
J Exp Med. 2005 Nov 7;202(9):1261-9
pubmed: 16275763
Oncogene. 2002 Apr 4;21(15):2347-56
pubmed: 11948418
EBioMedicine. 2019 Sep;47:184-194
pubmed: 31492560
J Bone Miner Res. 2014 Apr;29(4):804-19
pubmed: 23983218
J Cell Biochem. 1983;21(2):151-9
pubmed: 6309875
Arthritis Rheumatol. 2014 Aug;66(8):2210-21
pubmed: 24719382
Nat Rev Drug Discov. 2014 Feb;13(2):140-56
pubmed: 24481312
Nat Immunol. 2010 Oct;11(10):889-96
pubmed: 20856220
J Clin Invest. 2003 Mar;111(5):749-58
pubmed: 12618529
Blood. 2007 Apr 15;109(8):3253-9
pubmed: 17158225
Nature. 2000 Nov 30;408(6812):535-6
pubmed: 11117729
Br J Cancer. 1987 Jan;55(1):61-6
pubmed: 3814476
Curr Opin Cell Biol. 2001 Oct;13(5):555-62
pubmed: 11544023
J Exp Med. 2013 Oct 21;210(11):2257-71
pubmed: 24127488
Endocr Rev. 2008 Jun;29(4):403-40
pubmed: 18451259
J Clin Invest. 1992 Oct;90(4):1622-7
pubmed: 1383278
BMC Cancer. 2018 Jan 6;18(1):44
pubmed: 29306325
PLoS One. 2012;7(11):e48871
pubmed: 23173040
J Bone Miner Res. 2013 Dec;28(12):2463-75
pubmed: 23677868
J Biol Chem. 2000 Nov 24;275(47):37219-23
pubmed: 10954702
J Biol Chem. 1993 May 5;268(13):9901-7
pubmed: 8486670
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938